Achievement and Maintenance of Disease Targets with Upadacitinib in Rheumatoid Arthritis: 2-Year Outcomes from the UPHOLD Real-World Study.
- DOI
- 10.1007/s40744-026-00826-5
- Published
- 2026 Jun
- Container
- Rheumatology and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40744-026-00826-5,
title = {Achievement and Maintenance of Disease Targets with Upadacitinib in Rheumatoid Arthritis: 2-Year Outcomes from the UPHOLD Real-World Study.},
author = {Östör A and Feist E and Sidiropoulos P and Avouac J and Rebella M and Namas R and Buttgereit F and Conaghan PG and Romero AB and McDearmon-Blondell EL and Lagunes-Galindo I and Gao T and Kadakia A and Shaw T and Attar S},
year = {2026},
journal = {Rheumatology and therapy},
doi = {10.1007/s40744-026-00826-5},
url = {https://doi.org/10.1007/s40744-026-00826-5}
}RIS
TY - JOUR TI - Achievement and Maintenance of Disease Targets with Upadacitinib in Rheumatoid Arthritis: 2-Year Outcomes from the UPHOLD Real-World Study. AU - Östör A AU - Feist E AU - Sidiropoulos P AU - Avouac J AU - Rebella M AU - Namas R AU - Buttgereit F AU - Conaghan PG AU - Romero AB AU - McDearmon-Blondell EL AU - Lagunes-Galindo I AU - Gao T AU - Kadakia A AU - Shaw T AU - Attar S PY - 2026 JO - Rheumatology and therapy DO - 10.1007/s40744-026-00826-5 UR - https://doi.org/10.1007/s40744-026-00826-5 ER -
APA
A, Ö., E, F., P, S., J, A., M, R., R, N., F, B., PG, C., AB, R., EL, M., I, L., T, G., A, K., T, S., & S, A. (2026). Achievement and Maintenance of Disease Targets with Upadacitinib in Rheumatoid Arthritis: 2-Year Outcomes from the UPHOLD Real-World Study.. Rheumatology and therapy. https://doi.org/10.1007/s40744-026-00826-5
Source records
- pubmed · retrieved 2026-11-10T16:27:25.302Z